Discover All Events

The New Approaches to Target Identification & Validation online seminar, organized by Oxford Global Marketing Limited, is a scientific event dedicated to one of the most critical stages of pharmaceutical research—identifying and validating therapeutic targets. Scheduled for 17 November 2026, this online event brings together experts from pharmaceutical companies, biotechnology organizations, academia, and research institutions to discuss the latest innovations transforming early-stage drug discovery. The seminar is part of Oxford Global's Discovery & Development portfolio, which connects biopharma leaders with cutting-edge scientific knowledge and industry collaboration. Target identification and validation remain essential for the successful development of safe and effective medicines. With advances in artificial intelligence, CRISPR technologies, multi-omics, single-cell analysis, and computational biology, researchers now have access to more accurate methods for identifying disease mechanisms and selecting promising therapeutic targets. This seminar explores how these innovations are changing the future of drug development. Event The event provides an in-depth look at modern technologies that are improving the efficiency and accuracy of target discovery. Participants will hear from internationally recognized scientists who will discuss successful research strategies, emerging platforms, and practical applications that accelerate therapeutic innovation. The online format allows delegates from around the world to participate without travel while engaging directly with industry experts through live presentations and question-and-answer sessions. Why This Event Matters Developing new medicines begins with identifying biological targets that play a significant role in disease progression. Poor target selection is one of the primary reasons drug candidates fail during clinical development. This seminar demonstrates how researchers are using advanced computational tools, genomics, proteomics, transcriptomics, AI-driven analytics, and functional validation methods to increase confidence in therapeutic target selection. Attendees will gain valuable insights into reducing development risk while improving research productivity. Topics Covered The seminar explores a broad range of scientific subjects, including: Modern target identification strategies Functional target validation Artificial Intelligence in drug discovery CRISPR-based validation technologies Multi-omics integration Genomics and transcriptomics High-throughput screening Computational biology Machine learning applications Translational research Precision medicine Biomarker-supported target discovery Disease biology Emerging therapeutic modalities These topics provide attendees with practical knowledge that can immediately support research projects and accelerate innovation. Expert Speakers Oxford Global events feature leading experts from: Global pharmaceutical companies Biotechnology organizations Academic research institutes Clinical research organizations Technology innovators Drug discovery specialists Speakers share real-world examples of successful target identification programs, discuss challenges encountered during validation, and explain how emerging technologies are improving decision-making in pharmaceutical research. Learning Outcomes By attending the seminar, participants will learn how to: Improve confidence in target selection Apply AI to biological research Validate therapeutic hypotheses more efficiently Integrate omics datasets into research workflows Understand emerging technologies shaping drug discovery Evaluate new experimental validation methods Reduce risk during early-stage pharmaceutical development These insights can significantly improve both academic research and commercial drug development programs. Networking Opportunities Although delivered online, the seminar provides opportunities for meaningful interaction through live discussions and Q&A sessions. Participants can exchange ideas with experts and peers from pharmaceutical companies, biotechnology firms, research organizations, and universities worldwide. The virtual environment supports global collaboration while enabling participants to remain connected with the latest scientific developments. Who Should Attend? The seminar is particularly valuable for: Drug discovery scientists Pharmaceutical researchers Biotechnology professionals Translational medicine experts Molecular biologists Computational biologists Clinical researchers Bioinformatics specialists Academic investigators R&D managers Precision medicine professionals Early-stage researchers Whether working in industry or academia, attendees will gain practical knowledge applicable to current and future research projects. Technology and Innovation Emerging technologies continue to reshape pharmaceutical R&D. Sessions will explore how researchers are leveraging: Artificial Intelligence Machine Learning CRISPR gene editing Single-cell sequencing Multi-omics platforms Predictive analytics Cloud-based computational biology High-content screening These technologies help researchers identify novel therapeutic targets faster while improving reproducibility and reducing development costs. Benefits of Attending Participants can expect to: Stay informed about the latest target discovery strategies. Learn directly from internationally recognized experts. Explore innovative validation technologies. Understand practical applications of AI in drug discovery. Discover collaborative research opportunities. Gain insights that support future therapeutic development. Oxford Global Marketing Limited Oxford Global Marketing Limited is a UK-based scientific events organizer recognized for bringing together leaders from the pharmaceutical, biotechnology, healthcare, and life sciences sectors. Through conferences, online seminars, and industry forums, the organization supports collaboration, knowledge exchange, and innovation across the global research community. Its Discovery & Development portfolio focuses on accelerating early-stage R&D through expert-led educational events and networking opportunities. Final Thoughts New Approaches to Target Identification & Validation is an essential online seminar for professionals involved in modern drug discovery. By combining expert presentations, practical case studies, and discussions on AI, multi-omics, and advanced validation technologies, the event equips participants with the knowledge needed to improve therapeutic target selection and accelerate pharmaceutical innovation. Researchers, scientists, and industry professionals seeking to remain at the forefront of drug discovery will find this event an excellent opportunity to learn from global experts and explore the next generation of target identification strategies.

Transforming Classroom Literacy with Talk for WritingThe Talk for Writing Primary Literacy Conference in Huddersfield offers educators a immersive professional development opportunity designed to revolutionize the teaching of writing across primary education. Rooted in the innovative pedagogical approach developed by Pie Corbett and Julia Strong, this full-day event demonstrates how children can build deep linguistic confidence by first internalising spoken language patterns before putting pen to paper. Delegates will explore the core three-stage framework—Imitation, Innovation, and Independent Application—which equips pupils with the foundational tools to become articulate, creative, and confident writers across all genres. Mastering the Core Three-Stage FrameworkThroughout the conference, expert literacy trainers break down each phase of the Talk for Writing process with concrete classroom examples. Attendees will discover how oral storytelling, text mapping, and interactive actions help pupils retain complex text structures without relying on memorization. During the Imitation stage, educators will learn how to select and adapt model texts that target specific grammar and vocabulary objectives. Moving into Innovation, delegates will explore structured techniques for co-constructing stories with pupils, fostering collaborative creativity. Finally, the Independent Application stage equips teachers with formative assessment methods that encourage children to transfer learned structures into original compositions independently. Bridging the Gap Between Oral Language and Written WorkA major highlight of this conference focuses on bridging the persistent gap between spoken communication and high-quality written output. Key workshops address how to engage reluctant writers, particularly pupils who struggle with vocabulary retrieval or structural planning. Through 'Book-talk' and 'Writer-talk' methodologies, delegates will discover actionable ways to help pupils articulate creative decisions before writing. Attendees will also examine how targeted vocabulary games, role-play exercises, and shared writing sessions build rich language banks that directly translate into improved writing quality across EYFS, Key Stage 1, and Key Stage 2. Implementing a Whole-School Literacy StrategySuccessful literacy development requires a consistent and aligned approach across all year groups. This conference provides school leadership teams and English leads with practical guidance on embedding Talk for Writing into the wider curriculum. Sessions offer insight into curriculum mapping, managing progression from early years to upper primary, and sustaining long-term impact on national assessment benchmarks. Leaders will leave with actionable strategies for conducting peer observations, guiding internal CPD workshops, and fostering a school-wide culture where creative writing thrives naturally. Interactive Workshops and Real-World Case StudiesIn addition to keynotes, the Huddersfield conference incorporates hands-on breakout sessions where participants actively practice text mapping, shared writing, and live editing. Delegates will examine video case studies from certified Talk for Writing training centers showcasing real classroom transformations and measurable pupil outcomes. The event also presents dedicated opportunities to network with peer educators, share best practices, and discuss tailored solutions for unique school environ

The International Summit on Clinical Innovation, hosted in collaboration with the Alliance for Continuing Education in the Health Professions, is a premier gathering designed to bridge the gap between educational theory and clinical practice. Set in the vibrant city of Birmingham, UK, this upcoming summit focuses on the "Future of Global Healthcare Learning." As the healthcare landscape becomes increasingly digital and interconnected, the necessity for robust, evidence-based continuing education has never been more critical. The program is meticulously curated to address the dual challenges of rapid technological integration and the maintenance of high-quality patient outcomes. Attendees will engage in deep-dive sessions regarding the implementation of Artificial Intelligence in medical curricula, the ethics of global accreditation standards, and the psychological frameworks of adult learning in high-stress environments. Beyond the technical sessions, the summit serves as a vital networking hub. It brings together stakeholders from pharmaceutical industries, academic institutions, and health system leadership to discuss sustainable funding models for continuing medical education (CME). Participants will explore how to transition from traditional "compliance-based" learning to "impact-based" education that measurably improves population health. The event will also feature a dedicated track for the Certified Healthcare CPD Professional (CHCP) credentialing, providing localized guidance for UK and European practitioners seeking international recognition. Join us to redefine the standards of professional growth in the health sector.